St. Louis, Missouri - December 29, 2006 - Mount Sinai Medical School has purchased Partek Genomics Suite (Partek GS) software Partek Incorporated announced today.

Mount Sinai Medical School, located in Manhattan, NY, is well known for its research and academic pursuits. Partek GS will be used to analyze SNP and expression data. Partek GS is designed to import, analyze, and visualize high-dimensional genomic data. It is Affymetrix GeneChip-compatible^TM for exon, gene expression, chromosomal copy number, and tiling array analysis. Partek GS can analyze SNP data as well.

St. Louis, Missouri - December 28, 2006 - Schering AG has purchased Partek Genomics Suite (Partek GS) software Partek Incorporated announced today.

Schering AG, located in Berlin, Germany, has recently purchased Partek GS to analyze exon data. Schering specializes in the research and drug discovery of issues relating to gynecology, andrology, and oncology.

Partek GS is designed to import, analyze, and visualize high-dimensional genomic data. It is Affymetrix GeneChip-compatible^TM for exon, gene expression, chromosomal copy number, and tiling array analysis. Partek GS can analyze SNP data as well.

St. Louis, Missouri - December 27, 2006 - Galenea, a leading biotechnology company, has purchased Partek Genomics Suite (Partek GS) software Partek Incorporated announced today.

Galenea will use Partek Genomics Suite to analyze exon array data from their ground-breaking studies in schizophrenia and calcineurin, a serine/threonine protein phosphatase. Technologies developed by MIT and Rockefeller University, from which the company was formed, focus on the treatment of schizophrenia using calcineurin-related treatments. Calcineurin-related treatments are thought to be useful in treating and understanding schizophrenia because calcineurin dysfunction within the brain can contribute to the development of schizophrenia.

St. Louis, Missouri - December 22, 2006 - The Radboud University Nijmegen Medical Centre has purchased Partek Genomics Suite (Partek GS) software Partek Incorporated announced today.

The Department of Human Genetics at the Medical Centre will use Partek GS to analyze exon array data. The Department focuses on hereditary illnesses, such as congenital anomalies, cancer, and mental illness. The Radboud University Nijmegen Medical Centre is located in the Netherlands.

St. Louis, Missouri - December 21, 2006 - Lilly Systems Biology in Singapore has purchased Partek Genomics Suite (Partek GS) software Partek Incorporated announced today.

Lilly Singapore purchased Partek GS to analyze genomic data collected through various stages of drug trials. Known for their excellence in research and pharmaceuticals, Lilly has facilities around the world, and is headquartered in Indianapolis, Indiana, USA.

St. Louis, Missouri - December 20, 2006 - The University of Western Sydney, Australia, has purchased Partek Genomics Suite (Partek GS) software Partek Incorporated announced today.

The School of Biomedical and Health Sciences at the University of Western Sydney will use Partek GS to analyze and visualize microarray data generated from the department’s research pursuits.

Partek GS is designed to import, analyze, and visualize high-dimensional genomic data. It is Affymetrix GeneChip-compatible^TM for exon, gene expression, chromosomal copy number, and tiling array analysis. Partek GS can analyze SNP data as well.

St. Louis, Missouri - December 19, 2006 - The Friedrich Miescher Institute for Biomedical Research (FMI) has purchased Partek Genomics Suite (Partek GS) software Partek Incorporated announced today.

The Functional Genomics lab at FMI will use Partek Genomics Suite to import, analyze, and visualize high-dimensional tiling and exon array data from studies done in the Institute’s core focus areas of epigenetics, growth control, and neurobiology. Partek GS was chosen because the Functional Genomics lab houses an Affymetrix GeneChip microarray facility that is available to all researchers at the Institute, and Partek Genomics Suite is Affymetrix GeneChip-compatible^TM for exon, gene expression, chromosomal copy number, and tiling array analysis. The Friedrich Miescher Institute, located in Basel, Switzerland, is part of the Novartis Funding Program and is a founding member of the Swiss Array Consortium.

St. Louis, MO - December 14, 2006 - Partek Incorporated announced today that the Women’s & Children’s Hospital of Australia has purchased Partek Genomics Suite (Partek GS) software.

The Department of Genetic Medicine, at the Hospital, will use Partek GS to analyze data from various studies including cancer, birth defects, and metabolic disorders. The Women’s & Children’s Hospital, located in Adelaide, focuses on the well-being of patients by providing state of the art medical care, offering educational classes for individuals in the community and doing leading edge research in such areas as genetic disorders and infectious diseases.

St. Louis, MO - December 6, 2006 - Partek Incorporated announced today that the Sir Henry Wellcome Functional Genomics Facility, part of the University of Glasgow system, has purchased Partek Genomics Suite (Partek GS) software.

The Wellcome Facility runs and analyzes Affymetrix microarray experiments for the University. The Facility will use Partek GS to help analyze the data derived from the microarray studies.

St. Louis, MO - December 6, 2006 - Partek Incorporated announced today that Toronto General Hospital has purchased Partek Genomics Suite (Partek GS) software.

The Department of Circulatory and Respiratory Health, within the Hospital’s Research Institute, has purchased Partek GS to analyze data from heart and lung studies. Toronto General Hospital, part of the University Health Network of Canada, specializes in cardiac care and organ transplantation.